112 related articles for article (PubMed ID: 27107083)
1. Alternative Splicing of IGF1 Gene as a Potential Factor in the Pathogenesis of Peyronie's Disease.
Thomas CG; Psarros C; Gekas A; Vandoros GP; Philippou A; Koutsilieris M
In Vivo; 2016; 30(3):251-6. PubMed ID: 27107083
[TBL] [Abstract][Full Text] [Related]
2. Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.
Zorba OU; Sirma S; Ozgon G; Salabas E; Ozbek U; Kadioglu A
Adv Clin Exp Med; 2012; 21(5):607-14. PubMed ID: 23356197
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.
Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O
Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264
[TBL] [Abstract][Full Text] [Related]
4. [Gene expression profiles and effects of transforming growth factor-beta1 intervention in Peyronie's disease].
Wang Z; Liu JF; Zhou ZH; Zhang YF; Wang WJ; Zhang P; Selcuk Y; Guiting L; Lin CS
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):182-6. PubMed ID: 15062068
[TBL] [Abstract][Full Text] [Related]
5. Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie's disease.
Hassoba H; El-Sakka A; Lue T
Egypt J Immunol; 2005; 12(1):1-8. PubMed ID: 16734133
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
7. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease.
Piao S; Ryu JK; Shin HY; Zhang L; Song SU; Han JY; Park SH; Kim JM; Kim IH; Kim SJ; Suh JK
Int J Androl; 2008 Jun; 31(3):346-53. PubMed ID: 17651407
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
Bivalacqua TJ; Champion HC; Leungwattanakij S; Yang DY; Hyun JS; Abdel-Mageed AB; Sikka SC; Kadowitz PJ; Hellstrom WJ
J Androl; 2001; 22(3):497-506. PubMed ID: 11330651
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease.
Hauck EW; Hauptmann A; Schmelz HU; Bein G; Weidner W; Hackstein H
J Urol; 2003 Jan; 169(1):369-72. PubMed ID: 12478192
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.
Szardening-Kirchner C; Konrad L; Hauck EW; Haag SM; Eickelberg O; Weidner W
World J Urol; 2009 Feb; 27(1):123-30. PubMed ID: 18704440
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor expression in Peyronie's disease.
Mulhall JP; Thom J; Lubrano T; Shankey TV
J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
[TBL] [Abstract][Full Text] [Related]
14. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.
El-Sakka AI; Hassoba HM; Pillarisetty RJ; Dahiya R; Lue TF
J Urol; 1997 Oct; 158(4):1391-4. PubMed ID: 9302128
[TBL] [Abstract][Full Text] [Related]
15. RNA-sequencing profiling analysis of pericyte-derived extracellular vesicle-mimetic nanovesicles-regulated genes in primary cultured fibroblasts from normal and Peyronie's disease penile tunica albuginea.
Yin GN; Piao S; Liu Z; Wang L; Ock J; Kwon MH; Kim DK; Gho YS; Suh JK; Ryu JK
BMC Urol; 2021 Aug; 21(1):103. PubMed ID: 34362357
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in Peyronie's disease.
Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.
Gonzalez-Cadavid NF; Rajfer J
Nat Clin Pract Urol; 2005 Jun; 2(6):291-7. PubMed ID: 16474811
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene expression in the tunica albuginea of patients with Peyronie's disease. Pilot study with a control group.
Pavone C; Caruana G; Abbadessa D; Scaduto G; Gambino G; Serretta V; Alessandro R; Colomba P
Urologia; 2012 Jul; 79(3):189-96. PubMed ID: 23032634
[TBL] [Abstract][Full Text] [Related]
19. IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells.
Philippou A; Armakolas A; Panteleakou Z; Pissimissis N; Nezos A; Theos A; Kaparelou M; Armakolas N; Pneumaticos SG; Koutsilieris M
Anticancer Res; 2011 Dec; 31(12):4259-65. PubMed ID: 22199289
[TBL] [Abstract][Full Text] [Related]
20. Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts.
Del Carlo M; Cole AA; Levine LA
J Urol; 2008 Jun; 179(6):2447-55. PubMed ID: 18433786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
